Streetbeat News

Analyst Ratings

ARDX

HC Wainwright & Co. analyst Ed Arce has reiterated a 'Buy' rating on Ardelyx (NASDAQ:ARDX) and maintained a $9 price target.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 10:26 am

EYPT

HC Wainwright & Co. analyst Yi Chen has reiterated a 'Buy' rating on EyePoint Pharmaceuticals (NASDAQ:EYPT) and maintained a price target of $27.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 10:25 am

MLTX

HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a 'Buy' rating on MoonLake (NASDAQ:MLTX) and maintained a $75 price target.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 10:20 am

SLRN

HC Wainwright & Co. analyst Emily Bodnar has reiterated a 'Buy' rating on Acelyrin (NASDAQ:SLRN) and maintained a $30 price target.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 10:18 am

ALNY

Needham analyst Joseph Stringer has reiterated a 'Buy' rating on Alnylam Pharmaceuticals (NASDAQ:ALNY) and maintained a price target of $240.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 10:18 am

DAWN

Needham analyst Ami Fadia has reiterated a 'Buy' rating on Day One Biopharmaceutical (NASDAQ:DAWN) and maintained a price target of $34.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 10:16 am

MEG

Needham analyst James Ricchiuti has reiterated a 'Buy' rating on Montrose Environmental Gr (NYSE:MEG) and maintained a price target of $54.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 10:12 am

MLTX

Needham analyst Serge Belanger has reiterated a 'Buy' rating on MoonLake (NASDAQ:MLTX) and maintained a price target of $76.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 10:11 am

IFRX

HC Wainwright & Co. analyst Edward White has reiterated a 'Buy' rating on InflaRx (NASDAQ:IFRX), maintaining a price target of $9.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 10:11 am

F

NVDA

TSLA

Jim Cramer, host of CNBC's Mad Money, expressed skepticism about Morgan Stanley analyst Adam Jonas's upgrade of Tesla from Hold to Buy, citing the potential of Tesla's supercomputer Dojo. Cramer questioned whether Dojo could rival Nvidia and add $500 billion to Tesla's valuation. He also noted that Jonas missed Tesla's growth as a car company. Cramer has been bullish on Nvidia and lukewarm on Tesla, even recommending Ford over Tesla.

Portfolio Pulse from Shanthi Rexaline

September 12, 2023 | 9:59 am